Gastric and Small Bowel Tumors

L. Mark Knab; Anthony Yang

doi:10.1007/978-3-319-34244-3_1

Gastric and Small Bowel Tumors

L. Mark Knab
, Anthony Yang

Department of Surgery

Research output: Contribution to journal › Review article › peer-review

Abstract

The incidence of gastric adenocarcinoma has decreased in the United States over the past 70 years although it continues to have a poor prognosis. While radical resection was initially the primary treatment for adenocarcinoma of the stomach, systemic chemotherapy and radiation have been shown to play a role in prolonging survival in most patient populations. This chapter explores the evidence that guides treatment for gastric cancer today. It also discusses the treatment for gastrointestinal stromal tumors (GIST), and small bowel tumors. In addition to systemic therapies, this chapter explores the surgical management of gastric and small bowel tumors including the extent of the gastric lymph node dissection.

Original language	English (US)
Pages (from-to)	1-16
Number of pages	16
Journal	Cancer treatment and research
Volume	168
DOIs	https://doi.org/10.1007/978-3-319-34244-3_1
State	Published - Jan 1 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.1007/978-3-319-34244-3_1

Cite this

@article{bdff3d7f13bb4c48a22db19cf82697e4,

title = "Gastric and Small Bowel Tumors",

abstract = "The incidence of gastric adenocarcinoma has decreased in the United States over the past 70 years although it continues to have a poor prognosis. While radical resection was initially the primary treatment for adenocarcinoma of the stomach, systemic chemotherapy and radiation have been shown to play a role in prolonging survival in most patient populations. This chapter explores the evidence that guides treatment for gastric cancer today. It also discusses the treatment for gastrointestinal stromal tumors (GIST), and small bowel tumors. In addition to systemic therapies, this chapter explores the surgical management of gastric and small bowel tumors including the extent of the gastric lymph node dissection.",

author = "Knab, \{L. Mark\} and Anthony Yang",

year = "2016",

month = jan,

day = "1",

doi = "10.1007/978-3-319-34244-3\_1",

language = "English (US)",

volume = "168",

pages = "1--16",

journal = "Cancer treatment and research",

issn = "0927-3042",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Gastric and Small Bowel Tumors

AU - Knab, L. Mark

AU - Yang, Anthony

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The incidence of gastric adenocarcinoma has decreased in the United States over the past 70 years although it continues to have a poor prognosis. While radical resection was initially the primary treatment for adenocarcinoma of the stomach, systemic chemotherapy and radiation have been shown to play a role in prolonging survival in most patient populations. This chapter explores the evidence that guides treatment for gastric cancer today. It also discusses the treatment for gastrointestinal stromal tumors (GIST), and small bowel tumors. In addition to systemic therapies, this chapter explores the surgical management of gastric and small bowel tumors including the extent of the gastric lymph node dissection.

AB - The incidence of gastric adenocarcinoma has decreased in the United States over the past 70 years although it continues to have a poor prognosis. While radical resection was initially the primary treatment for adenocarcinoma of the stomach, systemic chemotherapy and radiation have been shown to play a role in prolonging survival in most patient populations. This chapter explores the evidence that guides treatment for gastric cancer today. It also discusses the treatment for gastrointestinal stromal tumors (GIST), and small bowel tumors. In addition to systemic therapies, this chapter explores the surgical management of gastric and small bowel tumors including the extent of the gastric lymph node dissection.

UR - https://www.scopus.com/pages/publications/85038641302

UR - https://www.scopus.com/pages/publications/85038641302#tab=citedBy

U2 - 10.1007/978-3-319-34244-3_1

DO - 10.1007/978-3-319-34244-3_1

M3 - Review article

C2 - 29206015

AN - SCOPUS:85038641302

SN - 0927-3042

VL - 168

SP - 1

EP - 16

JO - Cancer treatment and research

JF - Cancer treatment and research

ER -

Gastric and Small Bowel Tumors

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this